Effects of the CCR5-Δ32 mutation on antiviral treatment in chronic hepatitis C

This publication has 40 references indexed in Scilit:

• CCR5 (chemokine receptor-5) DNA-polymorphism influences the severity of rheumatoid arthritis
  Genes & Immunity, 2000
• Association of CCR5 ▵32 with reduced risk of asthma
  The Lancet, 1999
• Hepatitis C Viral Dynamics in Vivo and the Antiviral Efficacy of Interferon-α Therapy
  Science, 1998
• The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions.
  Journal of Clinical Investigation, 1998
• CCR5 Levels and Expression Pattern Correlate with Infectability by Macrophage-tropic HIV-1, In Vitro
  The Journal of Experimental Medicine, 1997
• Detection of Type 2–Like T–Helper Cells in Hepatitis C Virus Infection: Implications for Hepatitis C Virus Chronicity
  Hepatology, 1997
• Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the CKR5 Structural Gene
  Science, 1996
• Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene
  Nature, 1996
• An Algorithm for the Grading of Activity in Chronic Hepatitis C
  Hepatology, 1996
• Interferon for non-A, non-B chronic hepatitis: A meta-analysis of randomised clinical trials
  Journal of Hepatology, 1991